Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Receivables - Other data on file, last reported at $104052.5 in Q4 2025.

• Receivables - Other for Q4 2025 came in at $104052.5, up 1.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $104052.5 (up 1.28% YoY), and the FY2025 annual result was $102694.8, down 71.47% from the prior year.
• Receivables - Other climbed to $104052.5 in Q4 2025 per ZYBT's latest filing, from $103000.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $180831.4 in Q4 2023 and troughed at $102741.2 in Q4 2024.
• A 3-year average of $122656.3 and a median of $103526.3 in 2025 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other sank 43.18% in 2024, then advanced 1.28% in 2025.
• A 3-year view of Receivables - Other shows it stood at $180831.4 in 2023, then slumped by 43.18% to $102741.2 in 2024, then rose by 1.28% to $104052.5 in 2025.
• Business Quant data shows ZYBT's Receivables - Other at $104052.5 in Q4 2025, $103000.0 in Q2 2025, and $102741.2 in Q4 2024.